Publication | Closed Access
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial
190
Citations
26
References
2022
Year
After TAVI, apixaban was not superior to the standard of care, irrespective of an indication for oral anticoagulation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1